Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs Tripadvisor Inc Common Stock — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Tripadvisor Inc Common Stock trades at $13.14 (market cap $1.66B). The key difference: Adaptive Biotechnologies Corp is far larger — about 2× Tripadvisor Inc Common Stock's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals.
| ADPT | TRIP | |
|---|---|---|
Market Cap | $3.33B | $1.66B |
Sector | Health | Consumer Cyclical |
52-Week High | $22.37 | $19.14 |
52-Week Low | $10.24 | $9.24 |
Enterprise Value | $3.19B | $1.79B |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →